CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorZagazig University
About this trial
The goal of this clinical trial is to compare the effectiveness and safety of CT-guided versus fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation (TG-RFT) in treating idiopathic trigeminal neuralgia (TN) in adults aged 18 and older.
The main questions it aims to answer are:
* Does CT-guided TG-RFT provide better pain relief compared to fluoroscopy-guided TG-RFT? * What are the differences in medication consumption between the two methods? * What are the procedure-related adverse events for both methods?
Investigators will compare CT-guided TG-RFT to fluoroscopy-guided TG-RFT to see if one method is superior in treating idiopathic TN.
Participants will:
* Undergo either CT-guided or fluoroscopy-guided TG-RFT procedure * Be monitored post-procedure and followed up at 1, 3, and 6 months for pain relief, medication consumption, and adverse events.
Eligibility criteria
Qualifiers
Age >18 years
Idiopathic trigeminal neuralgia (TN) based on the International Headache Society criteria
Pain for at least six months and a NRS score greater than 6 despite medical treatment
Able to provide informed consent.
Disqualifiers
Vascular compression of the trigeminal nerve by MRI and MRI angiography and the presence of secondary causes such as multiple sclerosis
Trigeminal autonomic cephalalgias accompanied by autonomic symptoms
Dental or temporomandibular joint pathologies
Previous interventional procedures or surgery for TN
Trial design
Treatments tested in this trial
- CT-guided Radiofrequency Thermocoagulation (RFT)
- Fluoroscopy-guided Radiofrequency Thermocoagulation (RFT)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov